Accurately assessing the state of a patient's genome is one of the most powerful tools in the emerging field of personalized medicine. Let Five3 Genomics apply its leading genomic analyses to rapidly discover variants in a patient's raw genomics data using sequencing and chip-based technologies.
We annotate all variants against a knowledge database comprising all known and probable disease-associated genes to rank the genomic alterations that have the highest clinical relevance. When applied to cancer tumor/normal samples, our analysis is capable of quickly identifying genomic alterations that could lead to tumorigenesis for a fraction of the cost of conventional approaches.
- Mutation & SNP Discovery
- Highly-accurate Bayesian approach to identify germline and somatic variants.
- Variant Annotation
- Identify variants causing alterations in proteins and if they've been seen before in other cancers.
- Structural Variants
- Find rearrangements causing fusions or explain copy number alterations.